An intron 1 enhancer element mediates oestrogen-induced suppression of ERBB2 expression

Oncogene

Volumn 15, Issue 4, 1997, Pages 473-481

  Bates, Nicholas P ^a   Hurst, Helen C ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

DNase I hypersensitive sites; ERBB2; ERBB3; Oestrogen repression

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; BREAST CANCER; CELL TRANSFORMATION; CONTROLLED STUDY; DNA FOOTPRINTING; ENHANCER REGION; GENE REPRESSION; HUMAN; HUMAN CELL; INTRON; ONCOGENE NEU; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030865656     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201368     Document Type: Article

References (63)

1. Adnane J, Gaudray P, Simon M-P, Simony-Latontaine J, Jeanteur P and Theillet C. (1989). Oncogene, 4, 1389-1395.
2. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP and Kraus MH. (1995). Oncogene, 10, 1813-1821.
3. Antoniotti S, Taverna D, Maggiora P, Sapei ML, Hynes NE and DeBortoli M. (1994). Br. J. Cancer, 70, 1095-1101.
4. Bates NP and Hurst HC. (1996). Clinical Gene Analysis and Manipulation. Jankowski J and Polak J. (eds). Cambridge University Press: Cambridge, pp. 332-348.
5. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P, McKenzie S, Yin S and Bast Jr, RC. (1990). Cancer Res., 50, 4087-4091.
6. Borg A, Tandon AK, Sigurdsson H, Clark GM, Ferno M, Fuqua SAW, Killander D and McGuire WL. (1990). Cancer Res., 50, 4332-4337.
7. Brown AMC, Jeltsch J-M, Roberts M and Chambon P. (1984). Proc. Natl. Acad. Sci. USA, 81, 6344-6348.
8. Carraway KL and Cantley LC. (1994). Cell, 78, 5-8.
9. Chen YY and Gill GN. (1994). Oncogene, 9, 2269-2276.
10. Chrysogelos SA. (1993). Nucleic Acids Res., 21, 5736-5741.
11. Coussens L, Yang-Feng, TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A and Ullrich A. (1985). Science, 230, 1132-1139.
12. D'Souza B, Berdichevsky F, Kyprianou N and Taylor-Papadimitriou J. (1993). Oncogene, 8, 1797-1806.
13. Darbre P, Yates J, Curtis S and King RJB. (1983). Cancer Res., 43, 349-354.
14. Dati C, Antoniotti S, Taverna D, Perroteau I and De Bortoli M. (1990). Oncogene, 5, 1001-1006.
15. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, Richter King C and Aaronson SA. (1987). Science, 237, 178-182.
16. Dignam JD, Lebovitz RM and Roeder RG. (1983). Nucleic Acids Res., 11, 1475-1489.
17. Doucas V, Spyrou G and Yaniv M. (1991). EMBO J., 10, 2237-2245.
18. Early Breast Cancer Trialists Collaborative Group. (1992a). Lancet, 1, 1-15.
19. Early Breast Cancer Trialists Collaborative Group. (1992b). Lancet, 1, 71-85.
20. Gasparini G, Gullick WJ, Bevilacqua P, Sainsbury JRC, Meli S, Boracchi P, Testolin A, La Malfa G and Pozza F. (1992). J. Clin. Oncol., 10, 686-695.
21. Gasparini G, Gullick WJ, Maluta S, Dallapalma P, Caffo O, Leonardi E, Boracchi P, Pozza F, Lemoine NR and Bevilaqua P. (1994). Eur. J. Cancer, 30A, 16-22.
22. Grooteclaes M, Pasleau F, Dijkmans H, Berzi P, Albert A and Winklergol, R. (1994). Cancer Res., 54, 4193-4199.
23. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstum C-M, Golouh R, Reed R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville A-M, Burki K, Castiglione M, Collins J, Lindtner J and Senn H-J. (1992). J. Clin. Onc., 10, 1049-1056.
24. Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway KL. (1994). Proc. Natl. Acad. Sci. USA, 91, 8132-8136.
25. Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ and Lemoine NR. (1990). J. Path., 161, 195-200.
26. Hayward JL, Carbone PP, Heuson J-C, Kumaoka S, Segaloff A and Rubens RD. (1977). Eur. J. Cancer, 13, 89-94.
27. Hollywood DP and Hurst HC. (1993). EMBO J., 12, 2369-2375.
28. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P and Chambon P. (1984). Nucl. Acids Res., 12, 2861-2878.
29. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK and Rosenfeld MG. (1996). Cell, 85, 403-414.
30. Kato S, Tora L, Yamauchi J, Masushige S, Bellard M and Chambon P. (1992). Cell, 68, 731-742.
31. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L and Robinson R. (1990). Cancer Res., 50, 5184-5191.
32. King CR, Kraus MH and Aaronson SA. (1985). Science, 229, 974-976.
33. Kraus MH, Issing W, Miki T, Popescu NC and Aaronson SA. (1989). Proc. Natl. Acad. Sci. USA, 86, 9193-9197.
34. Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ and Hurst HC. (1992). Br. J. Cancer, 66, 1116-1121.
35. Miller SJ, Suen TC, Sexton TB and Hung M-C. (1994). Internat. J. Oncol., 4, 599-608.
36. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione MS, Budman DR, Wood WC, Barcos M and Henderson IC. (1994). New Eng. J. Med., 330, 1260-1266.
37. Plowman GD, Culouscou J-M, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG and Shoyab M. (1993a). Proc. Natl. Acad. Sci. USA, 90, 1746-1750.
38. Plowman GD, Green JM, Culouscou J-M, Carlton GW, Rothwell VM and Buckley S. (1993b). Nature, 366, 473-475.
39. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ and Shoyab M. (1990). Proc. Natl. Acad. Sci. USA, 87, 4905-4909.
40. Powles TJ, Tillyer CR, Jones AL, Ashley SE, Treleaven J, Davey JB and McKinna JA. (1990). Em. J. Cancer, 26, 680-684.
41. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, Paterson MC and Slamon DJ. (1993). Cancer Res., 53, 4960-4970.
42. Prigent SA and Gullick WJ. (1994). EMBO J., 13, 2831-2841.
43. Read LD, Keigh D, Slamon DJ and Katzenellenbogen BS. (1990). Cancer Res., 50, 3947-3951.
44. Roberts S and Bentley DL. (1992). EMBO J., 11, 1085-1093.
45. Russell KS and Hung M-C. (1992). Cancer Res., 52, 6624-6629.
46. Sarkar FH, Smith MR, Hoover T, Princier G, Crissmann JD, Visscher DW, Longo DL, Kung HF and Raziuddin. (1994). J. Biol. Chem., 269, 12285-12289.
47. Schule R and Evans RM. (1991). Trends Genet., 7, 377-381.
48. Scott GK, Daniel JC, Xiong X, Maki RA, Kabat D and Benz CC. (1994). J. Biol. Chem., 269, 19848-19858.
49. Semba K, Jamata N, Toyoshima K and Yamamoto T. (1985). Proc. Natl. Acad. Sci. USA, 82, 6497-6501.
50. Skinner A and Hurst HC. (1993). Oncogene, 8, 3393-3401.
51. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
52. Stein B and Yang MX. (1995). Mol. Cell. Biol., 15, 4971-4979.
53. Tal M, King CR, Kraus MH, Ullrich A, Schlessinger J and Givol D. (1987). Mol. Cell. Biol., 7, 2597-2601.
54. Tandon AK, Clark GM, Chamness GC, Ullrich A and McGuire WL. (1989). J. Clin. Oncol., 7, 1120-1128.
55. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I and Chambon P. (1989). EMBO J., 8, 1981-1986.
56. Tsu JY, Sun X-H, Kao T-H, Reece KS and Wu R. (1985). Nucleic Acids Res., 13, 2485-2502.
57. Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH. (1984). Nature, 309, 418-425.
58. Warri AM, Laine AM, Majasuo KE, Alitalo KK and Harkonen PL. (1991). Internat. J. Cancer, 49, 616-623.
59. Wright C, Angus B, Nicholson S, Sainsbury JRC, Cairns J, Gullick WJ, Kelly P, Harris A and Wilson Horne CH. (1989). Cancer Res., 49, 2087-2090.
60. Wright C, Nicholson S, Angus B, Sainsbury JRC, Farndon J, Cairns J, Harris AL and Horne CHW. (1992). Br. J. Cancer, 65, 118-121.
61. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T and Toyoshima K. (1986). Nature, 319, 230-234.
62. Yokota J, Yamamoto T, Toyoshima K, Terada M, Sugimura T, Battifora H and Cline MJ. (1986). Lancet, 1, 765-767.
63. Yonemura Y, Ninomiya I, Ohoyama S, Kimura H, Yamaguchi A, Fushida S, Kosaka T, Miwa K, Miyazaki I, Endou Y, Tanaka M and Sasaki T. (1991). Cancer, 67, 2914-2918.